1. 160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age. (31st December 2020) Authors: Chang, Leejah; Anderson, Evan J; Jeanfreau, Robert; He, Ying; Hicks, Bryony; Shrestha, Anju; Pandey, Aseem; Khoury, Rawia; De Bruijn, Iris; Landolfi, Victoria Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Issue 49 (1st December 2016) Authors: DeSilva, Malini; Munoz, Flor M.; Mcmillan, Mark; Kawai, Alison Tse; Marshall, Helen; Macartney, Kristine K.; Joshi, Jyoti; Oneko, Martina; Rose, Annette Elliott; Dolk, Helen; Trotta, Francesco; Spiegel, Hans; Tomczyk, Sylvie; Shrestha, Anju; Kochhar, Sonali; Kharbanda, Elyse O. Journal: Vaccine Issue: Volume 34:Issue 49(2016) Page Start: 6015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Issue 48 (4th December 2017) Authors: DeSilva, Malini; Munoz, Flor M.; Sell, Erick; Marshall, Helen; Tse Kawai, Alison; Kachikis, Alisa; Heath, Paul; Klein, Nicola P.; Oleske, James M.; Jehan, Fyezah; Spiegel, Hans; Nesin, Mirjana; Tagbo, Beckie N.; Shrestha, Anju; Cutland, Clare L.; Eckert, Linda O.; Kochhar, Sonali; Bardají, Azucena Journal: Vaccine Issue: Volume 35:Issue 48(2017)Part A Page Start: 6472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22. Issue 1 (29th November 2022) Authors: Gandhi‐Banga, Sonja; Wague, Sophie; Shrestha, Anju; Syrkina, Olga; Talanova, Oxana; Nissilä, Markku; Stuff, Karl; Monfredo, Céline Journal: Influenza and other respiratory viruses Issue: Volume 17:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry. Issue 1 (14th September 2021) Authors: Ledlie, Shaleesa; Gandhi‐Banga, Sonja; Shrestha, Anju; Mallett Moore, Tamala; Khromava, Alena Journal: Influenza and other respiratory viruses Issue: Volume 16:Issue 1(2022) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Growing teratoma syndrome: Two case reports. Issue 5 (9th May 2022) Authors: Shrestha, Anju; Dhakal, Hari; Pandey, Sirish Raj; Amatya, Kapendra Shekhar; Shrestha, Sudip; Tiwari, Prakash Nidhi; lama, Srijana Journal: Clinical case reports Issue: Volume 10:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial. Issue 12 (2nd December 2021) Authors: Pepin, Stephanie; Nicolas, Jean-François; Szymanski, Henryk; Leroux-Roels, Isabel; Schaum, Thomas; Bonten, Marc; Icardi, Giancarlo; Shrestha, Anju; Tabar, Cynthia Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 12(2021) Page Start: 5475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Issue 4 (April 2022) Authors: Izikson, Ruvim; Brune, Daniel; Bolduc, Jean-Sébastien; Bourron, Pierre; Fournier, Marion; Moore, Tamala Mallett; Pandey, Aseem; Perez, Lucia; Sater, Nessryne; Shrestha, Anju; Wague, Sophie; Samson, Sandrine I Journal: Lancet Issue: Volume 10:Issue 4(2022) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial. Issue 11 (12th March 2021) Authors: Chang, Lee-Jah; Anderson, Evan J.; Jeanfreau, Robert; He, Ying; Hicks, Bryony; Shrestha, Anju; Pandey, Aseem; Landolfi, Victoria; DeBruijn, Iris Journal: Vaccine Issue: Volume 39:Issue 11(2021) Page Start: 1572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial. Issue 15 (6th April 2023) Authors: Sanchez, Leilani; Nakama, Takahiro; Nagai, Hideaki; Matsuoka, Osamu; Inoue, Satoshi; Inoue, Takahiro; Shrestha, Anju; Pandey, Aseem; Chang, Lee-Jah; De Bruijn, Iris Journal: Vaccine Issue: Volume 41:Issue 15(2023) Page Start: 2553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗